Table 3.
Interaction between ACEINH and longitudinal cognitive function change in the Health ABC participants
p-value for ACEINH × Gene interaction on cognitive decline | ||
---|---|---|
Caucasians | African Americans | |
ACE-ID | ||
CLOX1 | 0.39 | 0.97 |
DSST | 0.46 | 0.14 |
3MSE | 0.46 | 0.14 |
AGT6 | ||
CLOX1 | 0.01 | 0.45 |
DSST | 0.22 | 0.06 |
3MSE | 0.22 | 0.06 |
AGTM235T | ||
CLOX1 | 0.01 | 0.64 |
DSST | 0.15 | 0.12 |
3MSE | 0.15 | 0.12 |
CLOX1: Executive clock draw test; DSST: Digit Symbol Substitution Test; 3MSE: Modified Mini Mental Status Examination; p-values are obtained from the Multivariate Mixed Models testing the hypothesis that the gene × ACEINH is significant on the longitudinal change in the cognitive test over the follow-up period. All models adjusted for age, sex, BMI, educational level, systolic blood pressure, stroke, APOE haplotypes, diabetes, baseline CLOX1 scores, and exposure to other high blood pressure medications.